Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
3,387 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00314106 | Chemotherapy, Irradiation, Cell Infusions, and Interleukin-2 to Treat Metastatic Melanoma | completed | Phase 2 | 26 | National Cancer Institute (NCI)NIH | 1 | Oct 18, 2012 | clinicaltrials |
| NCT00069160 | Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer | completed | Phase 2 | 48 | National Cancer Institute (NCI)NIH | 1 | Oct 12, 2012 | clinicaltrials |
| NCT00071058 | Surgery Plus Chemotherapy (Doxorubicin, Vincristine and Etoposide), Mitotane, and Tariquidar to Treat Adrenocortical Cancer | completed | Phase 2 | 50 | National Cancer Institute (NCI)NIH | 1 | Sep 18, 2012 | clinicaltrials |
| NCT00054665 | PS-341 Alone and PS-341 Plus EPOCH Chemotherapy to Treat Non-Hodgkin's Lymphoma | completed | Phase 2 | 50 | National Cancer Institute (NCI)NIH | 1 | Sep 11, 2012 | clinicaltrials |
| NCT00001941 | Anti-Tac for Treatment of Leukemia | completed | Phase 1 / Phase 2 | 34 | National Cancer Institute (NCI)NIH | 1 | Aug 20, 2012 | clinicaltrials |
| NCT00030992 | BMS 247550 to Treat Kidney Cancer | completed | Phase 2 | 102 | National Cancer Institute (NCI)NIH | 1 | Aug 20, 2012 | clinicaltrials |
| NCT00062933 | A Phase II Study of Isolated Hepatic Perfusion (IHP) in Patients With Ocular Melanoma | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Aug 20, 2012 | clinicaltrials |
| NCT00088374 | 17AAG to Treat Kidney Tumors in Von Hippel-Lindau Disease | completed | Phase 2 | 9 | National Cancer Institute (NCI)NIH | 1 | Jul 27, 2012 | clinicaltrials |
| NCT00972205 | Paclitaxel and CBT-1(Registered Trademark) to Treat Solid Tumors | completed | N/A | 12 | National Cancer Institute (NCI)NIH | 1 | Jul 19, 2012 | clinicaltrials |
| NCT00393094 | Bevacizumab and Irinotecan to Treat Brain Tumors | terminated | Phase 2 | 31 | National Cancer Institute (NCI)NIH | 1 | Jul 13, 2012 | clinicaltrials |
| NCT00445549 | Vandetanib to Treat Women With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | terminated | Phase 2 | 12 | National Cancer Institute (NCI)NIH | 1 | Jun 26, 2012 | clinicaltrials |
| NCT00001566 | A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas | completed | Phase 2 | 42 | National Cancer Institute (NCI)NIH | 1 | Jun 15, 2012 | clinicaltrials |
| NCT00080353 | Vaccine Treatment in Combination With IL-2 and Treated Lymphocytes for Advanced Melanoma | completed | Phase 2 | 58 | National Cancer Institute (NCI)NIH | 1 | Jun 14, 2012 | clinicaltrials |
| NCT00098254 | BAY 43-9006 (Sorafenib) to Treat Relapsed Non-Small Cell Lung Cancer | completed | Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | May 2, 2012 | clinicaltrials |
| NCT00040365 | Amifostine to Protect the Rectum During External Beam Radiotherapy for Prostate Cancer | completed | Phase 2 | 30 | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2012 | clinicaltrials |
| NCT00048893 | Vaccine and Chemotherapy for Previously Untreated Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | Apr 13, 2012 | clinicaltrials |
| NCT00036569 | A Phase II Study of Pegylated Interferon Alfa 2b (PEG-Intron(Trademark)) in Children With Diffuse Pontine Gliomas | completed | Phase 2 | 32 | National Cancer Institute (NCI)NIH | 1 | Feb 13, 2012 | clinicaltrials |
| NCT00047879 | Phase II Trial of Peginterferon Alpha-2b and Thalidomide in Adults With Recurrent Gliomas | completed | Phase 2 | 7 | National Cancer Institute (NCI)NIH | 1 | Oct 26, 2011 | clinicaltrials |
| NCT00629226 | Bortezomib, Cetuximab, and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage IV Head and Neck Cancer | completed | Phase 1 | 46 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2011 | clinicaltrials |
| NCT00393029 | Phase II Study of Metastatic Cancer That Overexpresses P53 Using Lymphodepleting Conditioning Followed by Infusion of Anti-P53 TCR-Gene Engineered Lymphocytes | completed | Phase 2 | 12 | National Cancer Institute (NCI)NIH | 1 | Aug 15, 2011 | clinicaltrials |
| NCT00342056 | Role of Gene Variation in Effectiveness of Gleevec Treatment | completed | — | 100 | National Cancer Institute (NCI)NIH | 2 | May 25, 2011 | clinicaltrials |
| NCT00340158 | Establishing an Inflammatory Breast Cancer Registry | completed | — | 164 | National Cancer Institute (NCI)NIH | 1 | Apr 23, 2010 | clinicaltrials |
| NCT00003801 | Health-Related Outcomes in Patients Who Were Previously Treated for Rhabdomyosarcoma | completed | N/A | — | National Cancer Institute (NCI)NIH | 0 | Aug 20, 2009 | clinicaltrials |
| NCT00096590 | Detecting Abnormal Blood Clotting in Patients With Metastatic Cancer Undergoing Surgery | completed | — | 60 | National Cancer Institute (NCI)NIH | 1 | May 12, 2009 | clinicaltrials |
| NCT00339248 | Markers for Breast Cancer | completed | — | 2,632 | National Cancer Institute (NCI)NIH | 1 | Mar 13, 2009 | clinicaltrials |
| NCT00004028 | Carmustine in Treating Patients With Recurrent Malignant Glioma | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00004080 | Gene Therapy in Treating Patients With Recurrent or Progressive Brain Tumors | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 0 | Feb 9, 2009 | clinicaltrials |
| NCT00004892 | O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00032097 | Motexafin Gadolinium in Treating Patients With Glioblastoma Multiforme Who Are Undergoing Radiation Therapy to the Brain | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00045474 | Brachytherapy in Treating Patients With Recurrent Malignant Glioma | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00053183 | Surgery Followed by Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00017264 | Atrasentan in Treating Patients With Progressive or Recurrent Malignant Glioma | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Jan 13, 2009 | clinicaltrials |
| NCT00075894 | Alanosine in Treating Patients With Progressive or Recurrent Malignant Gliomas | completed | Phase 1 | 18 | National Cancer Institute (NCI)NIH | 1 | Jan 13, 2009 | clinicaltrials |
| NCT00014521 | Karenitecin in Treating Patients With Recurrent Malignant Glioma | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00001158 | Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System | completed | — | — | National Cancer Institute (NCI)NIH | 1 | Mar 5, 2008 | clinicaltrials |
| NCT00001150 | Induction of Suction Blisters in Patients With Urticaria, Blistering Diseases, Inflammatory Dermatoses and Neoplastic Disorders, and in Normal Volunteers | completed | — | 2,000 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001188 | The Role of Multi-Modality Therapy for the Treatment of High-Grade Soft Tissue Sarcomas of the Extremities | completed | Phase 2 | 100 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001189 | The Treatment of Grade I Sarcomas and Benign, Non-Metastasizing Highly Invasive Soft Tissue Tumors | completed | Phase 2 | 150 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001193 | A Multimodality Treatment Approach to Patients With Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast Cancer | completed | Phase 2 | 200 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001209 | A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors | completed | Phase 1 | 120 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001217 | Osteosarcoma Study #2: A Randomized Trial of Pre-Surgical Chemotherapy vs. Immediate Surgery and Adjuvant Chemotherapy in the Treatment of Non-Metastatic Osteosarcoma. A Pediatric Oncology Group Phase III Study | completed | Phase 3 | 260 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001237 | Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas | completed | Phase 2 | 120 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001239 | Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast Cancer | completed | Phase 2 | 100 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001249 | Treatment of Tac-Expressing Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia (ATL) With Yttrium-90 Radiolabeled Anti-Tac | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001250 | Effect of Preoperative Chemotherapy on Axillary Lymph Node Metastases in Stage II Breast Cancer: A Prospective Randomized Trial | completed | Phase 2 | 130 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001266 | A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate Carcinoma | completed | Phase 2 | 70 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001269 | Phase I Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Plus GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) Plus Dose Escalation of IL-3 (Interleukin-3) in Metastatic Breast Cancer | completed | Phase 1 | 100 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001270 | Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma | completed | Phase 1 | 85 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001271 | A Phase I Study of Continuous Infusion Immunotoxin IgG-RFB4-SMPT-dgA in Refractory CD22 Positive B-Cell Lymphoma | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001272 | A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Stimulating Factor (G-CSF) in Previously Nontreated Ovarian Cancer Patients | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials